Nuplazid (pimavanserin) / Acadia Pharma  >>  Phase 4
Welcome,         Profile    Billing    Logout  

6 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Nuplazid (pimavanserin) / Acadia Pharma
NCT04188392: Pimavanserin for Insomnia In Veterans With Posttraumatic Stress Disorder

Completed
4
6
US
Pimavanserin, Nuplazid
Baylor College of Medicine
Post-traumatic Stress Disorder, Insomnia
10/21
11/21
NCT04292223: Open-Label Study With Pimavanserin on Activities of Daily Living in Subjects With Parkinson's Disease Psychosis

Checkmark Efficacy data from OLE study for Parkinson’s disease psychosis
Jun 2021 - Jun 2021: Efficacy data from OLE study for Parkinson’s disease psychosis
Completed
4
29
US
Pimavanserin, NUPLAZID
ACADIA Pharmaceuticals Inc.
Parkinson Disease Psychosis
04/22
04/22
NCT04809116: Pimavanserin for Insomnia in Veterans With Posttraumatic Stress Disorder: Proof of Concept

Withdrawn
4
20
US
Pimavanserin, Nuplazid
Baylor College of Medicine, ACADIA Pharmaceuticals Inc.
Insomnia Chronic, Posttraumatic Stress Disorder
12/23
12/23
NCT05357612: Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases

Recruiting
4
75
US
Pimavanserin
Vanderbilt University Medical Center, ACADIA Pharmaceuticals Inc.
Neurodegenerative Diseases, Parkinson Disease, Parkinson Disease Psychosis
06/25
08/25
CAMELOT, NCT05590637: Comparing Antipsychotic Medications in LBD Over Time

Recruiting
4
94
US
Pimavanserin, Nuplazid, Quetiapine, Seroquel
The University of Texas Health Science Center at San Antonio, Alzheimer's Association
Parkinson's Disease Psychosis, Dementia With Lewy Bodies
10/24
04/25
C-SAPP, NCT04373317: Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis

Recruiting
4
358
US
Pimavanserin, Quetiapine
VA Office of Research and Development
Parkinson's Disease Psychosis
10/25
08/26

Download Options